Baxter discontinues Revex injection

Baxter has announced it will discontinue manufacturing Revex (nalmefene HCl injection). Revex is an opioid antagonist indicated for the reversal of opioid drug effects and as an adjunct in the management of known or suspected opioid overdose.

For more information call (888) 229-0001 or visit www.fda.gov/cder/drug/shortages/default.htm#Revex.